Quiver Bioscience, formerly known as Q-State Biosciences, is a leading biotechnology company based in Cambridge, MA, dedicated to revolutionizing drug development for neurological diseases. With a decade of scientific advancements and cutting-edge technology, Quiver utilizes human disease models, artificial intelligence, and a state-of-the-art platform to discover and develop transformative medicines for patients living with brain disorders.
Driven by their innovative approach, Quiver integrates scalable biology, advanced engineering, and surrogate models to identify novel therapeutic targets and candidate molecules. Their proprietary cellular models capture the complexities of human biology, while their lineup of technologies and instrumentation measures hundreds of properties associated with cellular function per neuron. Through their analytics algorithms, Quiver extracts data from individual cells to gain insights into disease states and optimize therapeutic candidates with greater translational potential.
Generated from the website